Home » Business, Europe, Health & Medicine, Pharmaceuticals & Biotech » Cancer Gene Therapy Market: Global Industry Analysis Report, Share, Size, Growth, Price Trends and Forecast, 2024: Fractovia.org
“Major players include SiBiono., Shanghai Sunway Biotech company limited, Altor Bioscience Corporation, Amgen, BioCancell, Aduro Biotech, OncoGeneX, GlobeImmune, Inc., New Link Genetics., MolMed S.p.A, ZioPharm Oncology, Gradalis, GENELUX, MultiVir.”
Cancer Gene Therapy Market Size By Type [Gene Induced Immunotherapy (Cytokine Gene Delivery, Tumor Antigen Gene Delivery), Oncolytic Virotherapy (Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus, Herpes Simplex Virus, Alphavirus, Vaccinia Virus, Simian Virus), Gene Transfer/Gene Replacement (Naked/Plasmid Vectors, Electroporation, Sonoporation, Magnetofection, Gene Gun)]

As per Global Market Insights Inc. report, “The cancer gene therapy market worth USD 805.5 million in 2015, is anticipated to surpass USD 4.3 billion by 2024, growing at a CAGR of 20.7% over the period of 2016-2024.

Rapid technological breakthroughs and the rising acceptance of newly emerging genomic technologies like next-generation sequencing and high-density DNA microarrays is predicted to drive the cancer gene therapy market growth. Furthermore, the government support for these technologies is predicted to further boost the industry trends over the coming years. For instance, centers for disease control and prevention (CDC) favors countrywide screening programs for breast cancer control and cervical & colorectal cancers among women falling in low-income groups or with no health insurance.

Request for a sample of this research report @ https://www.fractovia.org/request-sample/204

Growing occurrence of cancer across the globe is expected to enrich the demand for gene therapy. As per the WHO report, cases of cancer are projected to increase by half and touch USD 15 million mark by the end of the decade. Cancer gene treatments are being carried out worldwide through various therapies such as oncolytic virotherapy, gene transfer, and gene induced immunotherapy.

The retroviral vector oncolytic virotherapy segment led the gene therapy industry in 2015 and is predicted to record a CAGR of 20.6% over the period of 2016-2024. It converts the single-stranded RNA into double-stranded DNA molecule that gradually integrates into the target genome and helps to stimulate the immune system.

U.S. Cancer Gene Therapy Market size, by type, 2012 – 2024 (USD Million)

U.S. Cancer Gene Therapy Market size, by type, 2012 - 2024 (USD Million)

The gene transfer therapy segment contributed about 46% of the overall revenue share in 2015 and is predicted to grow at a CAGR of 20.9% over the forecast timeframe. Furthermore, the gene induced immunotherapy segment contributed about 14% of the overall revenue share in 2015 and is projected to surpass USD 592.7 million by 2024. It is an innovative technique of adding new genes into cancer tumor that fights cancer cells. 

The U.S. cancer gene therapy market size worth USD 235 million in 2015, is predicted to grow at a CAGR of 20.9% over the forecast timeframe. Factors such as growing cases of cancers and acceptance of advanced methods of cancer treatments are predicted to drive the regional growth. In addition to this, heavy investments in R & D activities along with government support will boost the industry demand over the coming years. 

The China market worth USD 99.6 million in 2015, is predicted to grow at a CAGR of 21% over the forecast period owing to increase in healthcare funding coupled with improvement in R & D facilities. 

The Japan cancer gene therapy market worth USD 78.2 million in 2015, is predicted to grow at a CAGR of 20.9% over the period of 2016-2024. 

The UK market worth USD 92 million in 2015, is anticipated to register a CAGR of 20.8% over the forecast timeline due to the rising occurrence of cancer along with increasing acceptance of gene technology. 

Key industry participants include Amgen, SiBiono, GENELUX, Altor Bioscience Corporation, MolMed S.p.A, Shanghai Sunway Biotech Company limited, Gradalis, ZIOPHARM Oncology Incorporation, Aduro Biotech Incorporation, GlobeImmune Company, OncoGeneX, and New Link Genetics. These market participants will try to increase their revenue share by continuously investing in R & D activities to develop new methods of treatment. In addition to this, they will try to retain their market position by forming strategic alliances and through mergers & acquisitions.

Browse key industry insights spread across 105 pages with 125 market data tables & 6 figures & charts from the report, Cancer Gene Therapy Market Size By Type [Gene Induced Immunotherapy (Cytokine Gene Delivery, Tumor Antigen Gene Delivery), Oncolytic Virotherapy (Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus, Herpes Simplex Virus, Alphavirus, Vaccinia Virus, Simian Virus), Gene Transfer/Gene Replacement (Naked/Plasmid Vectors, Electroporation, Sonoporation, Magnetofection, Gene Gun)], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, China, Japan, Mexico, Brazil, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024 in detail along with the table of contents:

https://www.fractovia.org/news/industry-research-report/cancer-gene-therapy-market

 

Global Market Insights has segmented the cancer gene therapy industry on the basis of therapy type, and region

Cancer Gene Therapy Market Type Analysis (Revenue, USD Million, 2012 – 2024)

  • Gene induced immunotherapy
    • Delivery of cytokine gene
    • Delivery of Tumor antigen gene
  • Oncolytic Virotherapy
    • Adenoviruses
    • Lentiviruses
    • Retrovirus
    • Adeno Associated Virus
    • Herpes Simplex Virus
    • Alphavirus
    • Vaccinia Virus
    • Simian Virus
  • Gene transfer / Gene replacement
    • Naked/Plasmid Vectors
    • Electroporation
    • Sonoporation
    • Magnetofection
    • Gene Gun

Cancer Gene Therapy Market Regional Analysis (Revenue, USD Million, 2012 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Malaysia
    • Indonesia  
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • Kenya
  • Israel
  • Egypt

 

Browse Related Reports:

  • Cancer Biological Therapy Market Size By Product (Monoclonal Antibodies [Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bi-Specific Monoclonal Antibodies], Vaccines [Preventive, Therapeutic], Cancer Growth Blockers [Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors], Blood Cell Growth Factors [Lenograstim, Filgrastim], Cytokines [Interferons, Interleukins], Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

       https://www.fractovia.org/news/industry-research-report/cancer-biological-therapy-market

 

About Fractovia.org

Fractovia.org is one of India’s leading in-house and free news total admin portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers all across the globe.

Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue.

We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributers.

Media Contact
Company Name: Fractovia.org
Contact Person: Jack Davis
Email: sales@fractovia.org
Phone: 1-888-689-0688
Address:29L Atlantic Avenue, Suite L 105
City: Ocean View
State: Delaware
Country: United States
Website: https://www.fractovia.org/news/industry-research-report/cancer-gene-therapy-market

Comments are closed.